Sickle cell biomarkers and therapeutic targets
Wet-lab work analyzing sickle cell biomarkers, validating therapeutic targets and optimizing HEK293T cell cultures.
- When
- Dec 2024 – Dec 2025
- Role
- Undergraduate Researcher
- Lab
- Bao Lab, Laboratory of Biomolecular Engineering and Nanomedicine
- Institution
- Rice University
- Topics
- Sickle cell disease
- Gene editing
- Cell culture
- Methods
- Flow cytometry / FACS
- PCR / qPCR
- CRISPR/Cas9
- Transfection
Applied flow cytometry/FACS, PCR/qPCR, CRISPR/Cas9 gene editing, and transfection to analyze sickle cell biomarkers, validate therapeutic targets, and optimize HEK293T cell cultures.